Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dr Kingsley R Chin Forms New Spine Company NANISX LLC To Focus on Ambulatory Surgery Centers (ASC)


News provided by

KICVentures Group

Sep 05, 2022, 21:00 ET

Share this article

Share toX

Share this article

Share toX

NANISX LLC innovating outpatient spine technologies for Ambulatory Surgery Centers
NANISX LLC innovating outpatient spine technologies for Ambulatory Surgery Centers

Healthcare Investment Firm, KICVentures Group, owns NANISX LLC and sees the Newco formation strategy as a continuation of its pioneering movement to less exposure surgery (LES) of the spine in Ambulatory Surgery Centers (ASC). In the ASC model, there is growing demand for cost effective and less invasive technologies with proven outcomes.

MALDEN, Ma., Sept. 5, 2022 /PRNewswire-PRWeb/ -- Physician-owned ASCs performing spine procedures were once limited to Orthopedic Surgeons and Neurosurgeons but today there is rapidly more spine procedures being done outpatient by Interventional Pain Management (IPM) doctors such as Anesthesiologists, Physical Medicine and Rehabilitation Physiatrists, and Interventional Radiologists. NANISX LLC will be divided into two ASC divisions: NANISX Pain, focused on interventional pain management, and NANISX Ortho-Neuro. KICVentures Group has recently merged its holdings in three of its portfolio companies into NANISX that are already gaining market adoption in outpatient spine surgery: NanoFUSE Biologics, InSpan and Sacrix

"We are dedicated to support the rise in outpatient spine surgeries by training and equipping Interventional Pain Management doctors, Orthopedic surgeons and Neurosurgeons treating degenerative spinal stenosis and sacroiliac joint (SIJ) pain in ASCs for many years," says Dr Chin. In addition to being CEO and Founder of the KICVentures Group, Dr. Chin is a board-certified professor of orthopedic spine surgeon who in 2007 moved his medical practice as the Chief of Spine Surgery at the University of Pennsylvania to South Florida where he began his focus on ASC-based spine surgeries. Over the years, he has been expanding research publications, intellectual property and developing LES technologies and teaching physicians techniques to practice in ASCs. It is this firsthand experience that has allowed him to see the demand being generated by physician owners of ASCs who want direct access to technologies that are easy to use, appropriately priced for the ASC to make a profit, and are effective with proven outcomes and low risks of complications.

We are dedicated to support the rise in outpatient spine surgeries by training and equipping Interventional Pain Management doctors, Orthopedic surgeons and Neurosurgeons treating degenerative spinal stenosis and sacroiliac joint pain in ASCs - Kingsley R Chin MD MBA

Post this

NANISX LLC will have three leading outpatient spine technologies as a platform to offer the ASC. Sacrix is seeing growing demand as more ASC surgeries are being done to treat sacroiliac joint pain that can go unnoticed in 22% of low back pain sufferers as the source of back and radicular pain. Over 43% of lumbar instrumented spine fusions with pedicle screws will cause adjacent segment pain in the sacroiliac joint requiring surgery. Sacrix pioneered a patented platform of multi-threaded screws and fluted anti-rotational implants including a novel lateral-oblique percutaneous technique that can be done quickly with almost no bleeding through a 1.5 cm incision. Sacrix is experiencing robust demand since the recent announcement that a new T code X034T will be assigned to posterior intra-articular sacroiliac techniques in 2023. This would affect companies and devices doing posterior sacroiliac fusions that can no longer use the CPT 27279 code reserved for lateral fusion transfixing the sacroiliac joint that mainly Sacrix and SI-Bone do among few others. Many IPM doctors who do sacroiliac joint fusions have made the switch to Sacrix and are finding that Sacrix is also an improvement in providing greater fixation, easier technique and improved outcomes with no documented failures or complications.

InSpan's midline mini-open percutaneous interlaminar-interspinous device (IPD) is seeing growing adoption for treating spinal stenosis and for spinal fusion without the need for pedicle screws or interbody cages. Imagine doing a lumbar spine fusion quickly with no need for expensive navigation or robots to place pedicle screws with much less risk of complications, immediate pain relief and stabilization. NanoFUSE Biologics is the world's only FDA-approved fiber-based synthetic bioactive glass combined with demineralized bone matrix (DBM) for regenerative bone formation promoting fusion and bone healing. NanoFUSE when combined with an aqueous body fluid forms a 3D porous calcium hydroxyapatite layer for bone formation in as early as 24 hours.

NANISX believes it will take focused dedication to the ASC model to have sustainable adoption and growth but the timing is now. In contrast, the large spine manufacturers are investing more in hospitals anticipating growth with more expensive capital equipment like robots and navigation to place pedicle screws hoping that they can convince ASCs to adopt the same expensive hospital technologies and equipment. Large spine device manufacturers provide devices to hospitals as a commodity and sign exclusive agreements that exclude competition and innovation from smaller companies limiting doctors to use their devices. "KICVentures Group sees a different model for the ASC where the doctors are owners, and therefore empowered to make choices to use what is the most innovative and provide effective outcomes at a price that leaves them a profit by streamlining operational overhead," says CFO and Co-Founder, Aditya Humad.

NANISX portfolio of technologies are revenue and EBITDA positive and should grow rapidly with the expected addition of a new Chief Executive Officer (CEO) to be announced soon. We have also initiated the listing process to prepare for an IPO with a New York-based advisory firm which includes the search for the right governance and establishing processes to scale and be ready within 12 to 18 months.

INVESTORS
Series A Now open in KICVentures Group.
[email protected].

About NanoFUSE Biologics LLC
NanoFUSE Biologics LLC is privately owned by the KICVentures Group and has a proprietary fiber-based synthetic bioactive glass. NanoFUSE is the only FDA-approved combination of bioactive glass plus DBM and is proven for regenerating bone.
http://www.Nanofusebiologics.com

About INSPAN, LLC
InSpan LLC is privately owned by the KICVentures Group and is focused on advancing the platform of patented interspinous interlaminar fixation technology. The InSpan device has a proven ten-year track record with thousands implanted since FDA clearance in 2010. There are no documented device-related failures or spinous process fractures that have plagued other competitive ISP devices.
https://MyInspan.com/

About SACRIX LLC
Sacrix LLC is privately owned by the KICVentures Group and is focused on revolutionary percutaneous fluoroscopic lateral-oblique sacroiliac joint fusion technologies for the treatment of sacroiliac dysfunction and sacroiliitis. Sacrix developed its patented Sacrofuse threaded implant to be inserted percutaneously and received FDA clearance in 2015. The Gen1 Sacrofuse implant was compared head-to-head with market leader SI bone (SIBN) and found to have a 400% increase in pull-out strength. Sacrix has trained over 200 physicians to perform its revolutionary percutaneous lateral-oblique sacroiliac joint fusion technique safely and effectively through a 1.5 cm incision minimally invasively in outpatient ambulatory surgery centers.
http://www.MySacrix.com

About KICVentures Group
Founded in 2000 makes us the most experienced healthcare investment holding company with the largest portfolio of medical device technologies focused on solutions for less invasive outpatient spine surgery. Our investment strategy is to acquire or invent disruptive technologies using our own capital or partner with private individual investors. This allows us the freedom to make quick and nimble decisions such as when we acquired AxioMed Viscoelastic Disc Technologies while other firms invested in ball-and-socket articulating spacers.
http://www.KICVentures.com

Media Contact

Aditya Humad, KICVentures Group, 267-342-3968, [email protected]

SOURCE KICVentures Group

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.